Revenue decreased 12.1%
Revenue changed -12.1% from the comparable as-filed period.
$755.0M→$664.0M3 prior comparisons
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed -12.1% from the comparable as-filed period.
Selling, general & administrative changed +1.3% from the comparable as-filed period.
Inventory changed +0.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.